CURIA FRANCE SAS

Overview

CURIA FRANCE SAS is an active pharmaceutical ingredient (API) supplier with 2 active FDA Type II Drug Master Files, covering AZTREONAM ALFA FORM; AZTREONAM BETA FORM.

API / Drug Master Files

CURIA FRANCE SAS holds 2 active (2 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• AZTREONAM ALFA FORMActive2024-05-21
• AZTREONAM BETA FORMActive2023-05-12

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CURIA FRANCE SAS in our records. PharmaTek screens the full directory against live FDA enforcement data.